374 related articles for article (PubMed ID: 22520795)
1. Prospective analysis of 30-day safety and performance of transfemoral transcatheter aortic valve implantation with Edwards SAPIEN XT versus SAPIEN prostheses.
Eltchaninoff H; Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A
Arch Cardiovasc Dis; 2012 Mar; 105(3):132-40. PubMed ID: 22520795
[TBL] [Abstract][Full Text] [Related]
2. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve.
Mussardo M; Latib A; Chieffo A; Godino C; Ielasi A; Cioni M; Takagi K; Davidavicius G; Montorfano M; Maisano F; Carlino M; Franco A; Covello RD; Spagnolo P; Grimaldi A; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2011 Jul; 4(7):743-50. PubMed ID: 21777881
[TBL] [Abstract][Full Text] [Related]
3. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.
Durand E; Eltchaninoff H; Canville A; Bouhzam N; Godin M; Tron C; Rodriguez C; Litzler PY; Bauer F; Cribier A
Am J Cardiol; 2015 Apr; 115(8):1116-22. PubMed ID: 25726383
[TBL] [Abstract][Full Text] [Related]
5. Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis.
Borz B; Durand E; Godin M; Tron C; Canville A; Litzler PY; Bessou JP; Cribier A; Eltchaninoff H
Heart; 2013 Jun; 99(12):860-5. PubMed ID: 23236027
[TBL] [Abstract][Full Text] [Related]
6. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
[TBL] [Abstract][Full Text] [Related]
7. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
[TBL] [Abstract][Full Text] [Related]
8. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
9. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
[TBL] [Abstract][Full Text] [Related]
10. Transfemoral aortic valve implantation of an Edwards Sapien XT valve in a patient with a mechanical mitral prosthesis.
Fraccaro C; Tarantini G; Napodano M; Gasparetto V; Iliceto S; Gerosa G; Isabella G
J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):669-70. PubMed ID: 21430546
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
[TBL] [Abstract][Full Text] [Related]
12. Self-expanding Portico Valve Versus Balloon-expandable SAPIEN XT Valve in Patients With Small Aortic Annuli: Comparison of Hemodynamic Performance.
Del Trigo M; Dahou A; Webb JG; Dvir D; Puri R; Abdul-Jawad Altisent O; Campelo-Parada F; Thompson C; Leipsic J; Stub D; DeLarochellière R; Paradis JM; Dumont E; Doyle D; Mohammadi S; Pasian S; Côté M; Pibarot P; Rodés-Cabau J
Rev Esp Cardiol (Engl Ed); 2016 May; 69(5):501-8. PubMed ID: 26739827
[TBL] [Abstract][Full Text] [Related]
13. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.
Thomas M; Schymik G; Walther T; Himbert D; Lefèvre T; Treede H; Eggebrecht H; Rubino P; Colombo A; Lange R; Schwarz RR; Wendler O
Circulation; 2011 Jul; 124(4):425-33. PubMed ID: 21747054
[TBL] [Abstract][Full Text] [Related]
14. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry.
Bosmans JM; Kefer J; De Bruyne B; Herijgers P; Dubois C; Legrand V; Verheye S; Rodrigus I;
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):762-7. PubMed ID: 21349890
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
[TBL] [Abstract][Full Text] [Related]
16. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
[TBL] [Abstract][Full Text] [Related]
17. Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
Bandali A; Parry-Williams G; Kassam A; Palmer S; Williams PD; de Belder MA; Owens A; Goodwin A; Muir DF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):978-985. PubMed ID: 27189391
[TBL] [Abstract][Full Text] [Related]
18. Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry.
Romano M; Frank D; Cocchieri R; Jagielak D; Bonaros N; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Arne Rein K; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Bapat V
Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):757-764. PubMed ID: 28582580
[TBL] [Abstract][Full Text] [Related]
19. [POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities].
Zembala M; Wilczek K; Przybylski R; Chodór P; Nadziakiewicz P; Krasoń M; Sadowski J; Dudek D; Kapelak B; Forysz D; Witkowski A; Demkow M; Chmielak Z; Kuśmierski K; Juraszyński Z; Bochenek A; Cisowski M; Trusz-Gluza M; Buszman P; Woś S; Kalarus Z; Poloński L; Gasior M; Opolski G; Ruzyłło W
Kardiol Pol; 2009 Aug; 67(8):936-40. PubMed ID: 19784896
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience.
Latib A; Ielasi A; Montorfano M; Maisano F; Chieffo A; Cioni M; Mussardo M; Bertoldi L; Shannon J; Sacco F; Covello RD; Figini F; Godino C; Grimaldi A; Spagnolo P; Alfieri O; Colombo A
EuroIntervention; 2012 Mar; 7(11):1275-84. PubMed ID: 22278193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
